A potent, tissue-selective, synthetic inhibitor of HMG-CoA reductase.

Autor: Balasubramanian N; Cardiovascular Division, Bristol Myers Co., Wallingford, Connecticut 06492., Brown PJ, Catt JD, Han WT, Parker RA, Sit SY, Wright JJ
Jazyk: angličtina
Zdroj: Journal of medicinal chemistry [J Med Chem] 1989 Sep; Vol. 32 (9), pp. 2038-41.
DOI: 10.1021/jm00129a004
Databáze: MEDLINE